Using current techniques, Alzheimer’s disease, the most frequent cause of dementia, can only be detected once the typical plaques have formed in the brain. At this point, therapy seems no longer possible. However, the first changes caused by Alzheimer’s take place on the protein level up to 20 years sooner. A two-tier method developed at Ruhr-Universität Bochum (RUB) can help detect the disease at a much earlier stage. The researchers from Bochum published their report in the March 2019 edition of the journal “Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring”.
“This has paved the way for early-stage therapy approaches, where the as yet inefficient drugs on which we had pinned our hopes may prove effective,” says Professor Klaus Gerwert from the Department of Biophysics at RUB.
Protein folds incorrectly
In Alzheimer’s patients, the amyloid beta protein folds incorrectly due to pathological changes long before the first symptoms occur. A team of researchers headed by Klaus Gerwert successfully diagnosed this misfolding using a simple blood test; as a result, the disease can be detected approximately eight years before the first clinical symptoms occur. The test wasn’t suitable for clinical applications however: it did detect 71 per cent of Alzheimer’s cases in symptomless stages, but at the same time provided false positive diagnoses for nine per cent of the study participants. In order to increase the number of correctly identified Alzheimer’s cases and to reduce the number of false positive diagnoses, the researchers poured a lot of time and effort into optimising the test.
Second biomarker
As a result, they have now introduced the two-tier diagnostic method. To this end, they use the original blood test to identify high-risk individuals. Subsequently, they add a dementia-specific biomarker, namely tau protein, to run further tests with those test participants whose Alzheimer’s diagnosis was positive in the first step. If both biomarkers show a positive result, there is a high likelihood of Alzheimer’s disease. “Through the combination of both analyses, 87 of 100 Alzheimer’s patients were correctly identified in our study,” summarises Klaus Gerwert. “And we reduced the number of false positive diagnoses in healthy subjects to 3 of 100. The second analysis is carried out in cerebrospinal fluid that is extracted from the spinal cord.
“Now, new clinical studies with test participants in very early stages of the disease can be launched,” points out Gerwert. He is hoping that the existing therapeutic antibodies will still have an effect. “Recently, two major promising studies have failed, especially Crenezumab and Aducanumab – not least because it had probably already been too late by the time therapy was taken up. The new test opens up a new therapy window.”
“Once amyloid plaques have formed, it seems that the disease can no longer be treated,” says Dr. Andreas Nabers, head of the research group and co-developer of the Alzheimer’s sensor. “If our attempts to arrest the progression of Alzheimer’s fail, it will put a lot of strain on our society.”
Sensor test is simple and robust
The blood test has been upgraded to a fully automated process at the RUB Department of Biophysics. “The sensor is easy to use, robust when it comes to fluctuation in concentration of biomarkers, and standardised,” explains Andreas Nabers. “We are now conducting in-depth research to detect the second biomarker, namely tau protein, in the blood, in order to supply a solely blood-based test in future,” concludes Klaus Gerwert.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Alzheimer’s Association raising awareness by painting the Knoxville purpleon August 1, 2022 at 5:40 pm
The Knoxville office of the Alzheimer’s Association is gearing up for its annual Paint the Town Purple campaign which aims to raise awareness and funds for Alzheimer’s education, support and ...
- Alzheimer’s Association Research Finds Racial Disparities In Health Equity, Resources In Black, Brown Communitieson August 1, 2022 at 3:19 pm
Alzheimer's Association research found startling racial disparities in health equity and resources in Black and Brown communities.
- Major Developments From Researchers At Alzheimer's Association International Conferenceon August 1, 2022 at 2:55 pm
Natasha Brown reports.
- What allegations of Alzheimer’s research fraud mean for patientson August 1, 2022 at 1:05 pm
Not all Alzheimer’s research has been compromised by allegations of scientific fraud. But we should interrogate whether the governing bodies of research and drug approvals are truly effective.
- Is everything we think we know about Alzheimer's wrong?on August 1, 2022 at 10:36 am
If you've followed the news about Alzheimer's disease research in the past few months, you might find yourself wondering what else could go wrong.
- New Evidence Confirms Genetic Link Between Gut Health and Alzheimer’son August 1, 2022 at 10:00 am
Those with gastrointestinal disorders may be at greater risk of developing Alzheimer's disease, as there is a genetic link between the two, according to new research from Edith Cowan University.
- ALZHEIMER'S ASSOCIATION LAUNCHES ALZ-NET: A LONG-TERM DATA COLLECTION AND SHARING NETWORK FOR NEW TREATMENTSon August 1, 2022 at 8:17 am
The Alzheimer's Association announces that the Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) — a new platform that will collect long-term clinical and safety data from patients treated ...
- The Woman's Doctor: Alzheimer's Disease is twice as common in womenon August 1, 2022 at 6:50 am
In this Woman's Doctor segment, we discuss Alzheimer's Disease. It is twice as common in women compared to men.
- Loss of smell is a warning sign of Alzheimer’s. What if you lose your sense of smell from Covid?on August 1, 2022 at 6:20 am
New findings suggest there might be a connection between Covid-related loss of smell and cognitive impairment, but experts say more research is needed.
- The Alzheimer’s Association recognizes seven researchers for contributions to the field of dementia scienceon August 1, 2022 at 5:34 am
The Alzheimer’s Association will present seven awards at the Alzheimer’s Association International Conference 2022, recognizing researchers for their varied expertise, noteworthy achievements and ...
via Bing News